Page last updated: 2024-10-30

edaravone and Epilepsy

edaravone has been researched along with Epilepsy in 3 studies

Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)

Research Excerpts

ExcerptRelevanceReference
"The effects of edaravone against pentylenetetrazole (PTZ)-induced epilepsy in male albino rats were investigated."7.91Edaravone acts as a potential therapeutic drug against pentylenetetrazole-induced epilepsy in male albino rats by downregulating cyclooxygenase-II. ( Liu, LM; Lu, Y; Wang, N; Wang, WP, 2019)
"The effects of edaravone against pentylenetetrazole (PTZ)-induced epilepsy in male albino rats were investigated."3.91Edaravone acts as a potential therapeutic drug against pentylenetetrazole-induced epilepsy in male albino rats by downregulating cyclooxygenase-II. ( Liu, LM; Lu, Y; Wang, N; Wang, WP, 2019)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, Z1
Yang, C1
Meng, X1
Li, Z1
Lv, C1
Cao, P1
Liu, LM1
Wang, N1
Lu, Y1
Wang, WP1
Miyamoto, R1
Shimakawa, S1
Suzuki, S1
Ogihara, T1
Tamai, H1

Other Studies

3 other studies available for edaravone and Epilepsy

ArticleYear
Neuroprotection of edaravone on the hippocampus of kainate-induced epilepsy rats through Nrf2/HO-1 pathway.
    Neurochemistry international, 2018, Volume: 112

    Topics: Animals; Edaravone; Epilepsy; Free Radical Scavengers; Heme Oxygenase-1; Hippocampus; Kainic Acid; M

2018
Edaravone acts as a potential therapeutic drug against pentylenetetrazole-induced epilepsy in male albino rats by downregulating cyclooxygenase-II.
    Brain and behavior, 2019, Volume: 9, Issue:1

    Topics: Animals; Antioxidants; Brain; Convulsants; Cyclooxygenase 2; Disease Models, Animal; Down-Regulation

2019
Edaravone prevents kainic acid-induced neuronal death.
    Brain research, 2008, May-13, Volume: 1209

    Topics: Aldehydes; Animals; Antipyrine; Brain; Cell Death; Disease Models, Animal; Down-Regulation; Edaravon

2008